Celadon Pharmaceuticals PLC
LSE:CEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
UK |
|
Next Biometrics Group ASA
OSE:NEXT
|
NO |
|
S
|
Swiggy Ltd
NSE:SWIGGY
|
IN |
|
Matrimony.Com Ltd
NSE:MATRIMONY
|
IN |
|
U
|
Universe Printshop Holdings Ltd
HKEX:8448
|
HK |
|
Lear Corp
NYSE:LEA
|
US |
|
Dongbang Agro Corp
KRX:007590
|
KR |
|
G
|
Goldhills Holding Ltd
XTSX:GHL
|
CA |
|
M
|
M Yochananof and Sons 1988 Ltd
TASE:YHNF
|
IL |
|
Red Sky Energy Ltd
ASX:ROG
|
AU |
|
M
|
Map Boga Adiperkasa Tbk PT
IDX:MAPB
|
ID |
|
Ausgold Ltd
ASX:AUC
|
AU |
|
Guizhou Redstar Developing Co Ltd
SSE:600367
|
CN |
|
Shanxi Taigang Stainless Steel Co Ltd
SZSE:000825
|
CN |
|
Y
|
YTL Hospitality REIT
KLSE:YTLREIT
|
MY |
|
Jiangsu Xiehe Electronic Co Ltd
SSE:605258
|
CN |
|
NetSol Technologies Inc
NASDAQ:NTWK
|
US |
|
Sihayo Gold Ltd
ASX:SIH
|
AU |
|
Global Water Resources Inc
NASDAQ:GWRS
|
US |
Celadon Pharmaceuticals PLC
Summerway Capital Plc engages in acquiring companies or businesses that has the potential for strategic, operational, and performance improvement. The firm is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The firm is focused on growing indoor hydroponic cannabis initially for the chronic pain market. The company is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions such as autism. The firm's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control. The firm's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.
Summerway Capital Plc engages in acquiring companies or businesses that has the potential for strategic, operational, and performance improvement. The firm is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The firm is focused on growing indoor hydroponic cannabis initially for the chronic pain market. The company is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions such as autism. The firm's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control. The firm's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.
